Copyright
©The Author(s) 2016.
World J Gastroenterol. Apr 14, 2016; 22(14): 3852-3859
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3852
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3852
Table 1 Expression of integrin αvβ6 and MMP-9 and patient characteristics
Characteristic | No. | αvβ6 | P value | MMP-9 | P value | ||
Negative | Positive | Negative | Positive | ||||
Age (yr) | |||||||
< 60 | 51 | 33 | 18 | 31 | 20 | ||
> 60 | 75 | 49 | 26 | 0.942 | 42 | 33 | 0.593 |
Gender | |||||||
Male | 78 | 50 | 28 | 43 | 35 | ||
Female | 48 | 32 | 16 | 0.769 | 30 | 18 | 0.416 |
Location | |||||||
Upper | 27 | 20 | 7 | 16 | 11 | ||
Middle | 51 | 28 | 23 | 28 | 23 | ||
Lower | 48 | 34 | 14 | 0.136 | 29 | 19 | 0.847 |
Lauren type | |||||||
Intestinal | 83 | 47 | 36 | 46 | 37 | ||
Diffuse | 43 | 35 | 8 | 0.006 | 27 | 16 | 0.427 |
Differentiation | |||||||
Well | 19 | 15 | 4 | 6 | 13 | ||
Moderate | 30 | 14 | 16 | 18 | 12 | ||
Poor | 77 | 53 | 24 | 0.038 | 49 | 28 | 0.039 |
T stage | |||||||
T1 | 14 | 10 | 4 | 3 | 11 | ||
T2 | 13 | 7 | 6 | 8 | 5 | ||
T3 | 18 | 10 | 8 | 14 | 4 | ||
T4 | 81 | 55 | 26 | 0.578 | 48 | 33 | 0.014 |
N stage | |||||||
N0 | 37 | 26 | 11 | 18 | 19 | ||
N1 | 17 | 12 | 5 | 10 | 7 | ||
N2 | 26 | 10 | 16 | 11 | 15 | ||
N3 | 46 | 34 | 12 | 0.016 | 34 | 12 | 0.033 |
M stage | |||||||
M0 | 124 | 81 | 43 | 73 | 51 | ||
M1 | 2 | 1 | 1 | 0.652 | 0 | 2 | 0.094 |
TNM stage | |||||||
I | 12 | 4 | 8 | 3 | 9 | ||
II | 42 | 36 | 6 | 22 | 20 | ||
III | 70 | 41 | 29 | 48 | 22 | ||
IV | 2 | 1 | 1 | 0.002 | 0 | 2 | 0.008 |
Table 2 Expression correlation of integrin αvβ6 and MMP-9
αvβ6 expression | MMP-9 expression | Total | |
Negative | Positive | ||
Negative | 56 | 26 | 82 |
Positive | 17 | 27 | 44 |
Total | 73 | 53 | 126 |
Table 3 Univariate and multivariate analyses comparing overall survival to prognostic factors in 126 gastric cancer patients
Factors | Univariate analysis | Multivariate analysis | ||
Relative risk (95%CI) | P value | Relative risk (95%CI) | P value | |
Age (yr) | ||||
< 60 | 1 | |||
> 60 | 1.800 (1.090-2.973) | 0.258 | ||
Gender | ||||
Female | 1 | |||
Male | 1.450 (0.882-2.381) | 0.143 | ||
Location | ||||
Upper | 1 | |||
Middle/Lower | 1.171 (0.856-1.602) | 0.323 | ||
Lauren type | ||||
Intestinal | 1 | |||
Diffuse | 1.836 (1.061-3.177) | 0.03 | 1.431 (0.805-2.545) | 0.222 |
Differentiation | ||||
Well | 1 | |||
Moderate/Poor | 1.045 (0.764-1.429) | 0.784 | ||
T stage | ||||
T1 | 1 | 1 | ||
T2-4 | 1.295 (1.006-1.668) | 0.050 | 1.248 (0.813-1.916) | 0.311 |
N stage | ||||
N0 | 1 | 1 | ||
N1-3 | 1.343 (1.105-1.633) | 0.003 | 1.249 (0.818-1.909) | 0.303 |
M stage | ||||
M0 | 1 | 1 | ||
M1 | 26.25 (2.887-238.81) | 0.004 | 8.555 (0.735-99.62) | 0.087 |
TNM stage | ||||
I | 1 | 1 | ||
II-IV | 2.314 (1.502-3.565) | < 0.001 | 1.654 (0.643-4.257) | 0.296 |
αvβ6 | ||||
Negative | 1 | 1 | ||
Positive | 2.862 (1.452-3.747) | < 0.001 | 2.632 (1.569-4.416) | 0.003 |
MMP-9 | ||||
Negative | 1 | 1 | ||
Positive | 2.193 (1.110-2.787) | 0.005 | 1.813 (1.398-2.351) | 0.007 |
- Citation: Lian PL, Liu Z, Yang GY, Zhao R, Zhang ZY, Chen YG, Zhuang ZN, Xu KS. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer. World J Gastroenterol 2016; 22(14): 3852-3859
- URL: https://www.wjgnet.com/1007-9327/full/v22/i14/3852.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i14.3852